2025. Comparison of Deferasirox and Desferrioxamine as Iron Chelators in Multi-Transfused Pediatric Patients with Beta Thalassemia Major. Pakistan Journal of Medical & Cardiological Review. 4, 3 (Aug. 2025), 1214–1223.